Key facts
- This page summarizes Michael J. Catelani's Form 4 filing for Anixa Biosciences Inc (ANIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 30 Sep 2026, 10:25.
Michael J. Catelani - 30 Sep 2026 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)
- Reporting relationship
- President, COO, & CFO
- Issuer ticker
- ANIX
- Reported as of
- 30 Sep 2026
- Net transaction value
- +$15,620
- SEC form
- 4
- Accepted by SEC
- 30 Sep 2026, 10:25:37 UTC
- Prior SEC filing
- 06 Jan 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael J. Catelani
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael J. Catelani filed Form 4 for Anixa Biosciences Inc (ANIX) on 30 Sep 2026.
Change
- Previous filing in this sequence was filed on 06 Jan 2026.
- Current net transaction value: +$15,620.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001689394
Primary reporting owner
Catelani Michael
- Relationship
- President, COO, & CFO
- Address
- C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE,
- Signature
- /s/ Michael J. Catelani
- Signature date
- 30 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ANIX
transaction
Common Stock
Purchase
- Transaction value
- $15,620
- Shares
- +5,500
- Change %
- +12%
- Price
- $2.84
- Shares after
- 50,000
- Date
- 30 Sep 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.